Materia Medica Holding
Quick facts
Marketed products
- Anaferon · Other
- Anaferon for Children · Immunology / Virology
Anaferon for Children is an immunomodulatory agent that stimulates interferon production and enhances innate immune responses to combat viral infections. - Divaza · Other
- Ergoferon · Other
- Kolofort · Other
- Rengalin · Other
- Subetta · Other
- Tenoten · Other
- Tenoten for children · Psychiatry/Neurology
Tenoten for children is a homeopathic preparation that modulates stress-related neurobiological pathways to reduce anxiety and improve emotional regulation in pediatric patients.
Phase 3 pipeline
- Afalaza · Other
- Dietressa · Other
- MMH-MAP · Oncology
MMH-MAP is a monoclonal antibody targeting the PD-1 receptor. - Placebo (liquid dosage form)
This drug has no known mechanism of action. - Prospekta · Other
- Raphamin · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Materia Medica Holding
What are Materia Medica Holding's marketed drugs?
Top marketed products include Anaferon, Anaferon for Children, Divaza, Ergoferon, Kolofort, Rengalin.
What is Materia Medica Holding's pipeline?
Materia Medica Holding has 6 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Afalaza, Dietressa, MMH-MAP, Placebo (liquid dosage form).
Related
- Anaferon · Other
- Anaferon for Children · Immunology / Virology
- Divaza · Other
- Ergoferon · Other
- Kolofort · Other
- Sector hub: All tracked pharma companies